Disease-modifying anti-rheumatic drugs (DMARDs) for Sjogren’s syndrome

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the benefits and harms of DMARDs in the treatment of Sjögren’s syndrome.

This is a protocol.